These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2587937)

  • 61. Class-II HLA restriction of antigen-specific human T-lymphocyte clones. Evidence of restriction elements on both DR and MT molecules.
    Qvigstad E; Thorsby E
    Scand J Immunol; 1983 Oct; 18(4):299-306. PubMed ID: 6196836
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
    Gessl A; Waldhäusl W
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fine antigen specificity of human gamma delta T cell lines (V gamma 9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis.
    Mochizuki M; Suzuki N; Takeno M; Nagafuchi H; Harada T; Kaneoka H; Yamashita N; Hirayama K; Nakajima T; Mizushima Y
    Eur J Immunol; 1994 Jul; 24(7):1536-43. PubMed ID: 7517873
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
    Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
    J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells.
    Wyss-Coray T; Brander C; Frutig K; Pichler WJ
    Eur J Immunol; 1992 Sep; 22(9):2295-302. PubMed ID: 1381313
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human antigen-presenting cells: characterization of the cells in the T-lymphocytes proliferative response.
    Koide Y; Awashima F; Akaza T; Yoshida TO
    Microbiol Immunol; 1981; 25(5):489-503. PubMed ID: 6456403
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The role of the HLA system in the genetics of Type I diabetes mellitus].
    Deschamps I; Khalil I
    Diabete Metab; 1992; 18(4):253-63. PubMed ID: 1459312
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
    Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
    Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cell-mediated PPD-specific cytotoxicity against human monocyte targets: evidence for restriction by class II HLA antigens.
    Hansen PW; Madsen M; Christiansen SE; Johnsen HE; Kissmeyer-Nielsen F
    Tissue Antigens; 1984 Mar; 23(3):171-80. PubMed ID: 6610225
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
    Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
    J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
    [TBL] [Abstract][Full Text] [Related]  

  • 73. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
    Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
    Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
    Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
    Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human T cell clones with specificity for insulinoma cell antigens.
    Van Vliet E; Roep BO; Meulenbroek L; Bruining GJ; De Vries RR
    Eur J Immunol; 1989 Jan; 19(1):213-6. PubMed ID: 2465903
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones.
    Zanni MP; von Greyerz S; Schnyder B; Wendland T; Pichler WJ
    Int Immunol; 1998 Apr; 10(4):507-15. PubMed ID: 9620607
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera.
    Bergholtz BO; Thorsby E
    Scand J Immunol; 1978; 8(1):63-73. PubMed ID: 81515
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HLA-D/DR restriction of macrophage-dependent antigen activation of immune T lymphocytes: cross-reacting allogeneic HLA-D/DR may partly substitute for self HLA-D/DR.
    Bergholtz BO; Thoresen AB; Thorsby E
    Scand J Immunol; 1980; 11(5):541-8. PubMed ID: 6155693
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Both HLA-DR restricted and nonrestricted functions of adherent cells are required for induction of T lymphocyte proliferative responses.
    Koide Y; Awashima F; Akaza T; Yoshida TO
    Hum Immunol; 1981 Dec; 3(4):313-24. PubMed ID: 6976958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.